What the business is, and whether it's a good one at a fair price.
Operates a multi-specialty hospital chain across several Indian states including Telangana, Andhra Pradesh, Karnataka, Maharashtra, and Kerala. Revenue is generated from inpatient and outpatient hospital services, with Q4 FY26 inpatient volumes up 17.9% YoY and outpatient volumes up 30.1% YoY. The company expanded into 8 new locations in FY26 — Kompally, Guntur (two facilities), Thane, Sangli, Bangalore Mahadevapura and Electronic City, Kerala Kollam, plus a mother-and-child unit at Nellore — and is consolidating the 300-bed Palakkad acquisition. Mature hospitals run at ~29.5% EBITDA margin, while overall FY26 EBITDA margin was 20.9% as newly commissioned units dragged INR 128 crore on EBITDA. Employee costs of 17.5% of revenue are the largest disclosed cost line, with capex at 36.6% of revenue reflecting the build-out. A INR 1,500 crore QIP closed in June 2026 is being used to retire ~INR 1,000 crore of debt and target net debt/EBITDA of ~2x against ~3.5x currently.
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from KRISHNA INST OF MED SCI L's filed financials and exchange disclosures
KRISHNA INST OF MED SCI L is a Healthcare Services company listed on NSE and BSE, trading under the symbol KIMS.
Yes. Over the trailing twelve months KRISHNA INST OF MED SCI L reported a net profit of ₹194 Cr on revenue of ₹4,213 Cr.
Yes. The dividend yield is 0.64% at the current price. It paid out 86% of its profit as dividend in FY26.
No. Debt stands at 1.27× equity, and it carries net debt of ₹3,189 Cr. That is lower than 0% of its 24 Hospital peers.
On trailing P/E, KRISHNA INST OF MED SCI L ranks 28 of 30 in Hospital — cheaper than 7% of them, against an industry median of 47.3×. This is a position, not a valuation judgement.
On a typical session KRISHNA INST OF MED SCI L moves 1.16% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by KRISHNA INST OF MED SCI L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
